Mountain View Pharmaceuticals receives European patent on potential long-acting drug for multiple sclerosis
Mountain View Pharmaceuticals, 11 Jun 2012
Accessed on 12 Jun 2012 from http://www.mvpharm.com/Documents/MVP%20Receives%20European%20Patent%20on%20Long-Acting%20MS%20Drug%20June%2011,%202012.pdf.